ALZECURE PHARMA (Germany) Today
| AC6 Stock | EUR 0.30 0.02 7.14% |
PerformanceOK
| Odds Of DistressLow
|
ALZECURE PHARMA is trading at 0.3 as of the 22nd of July 2025. This is a 7.14 percent increase since the beginning of the trading day. The stock's lowest day price was 0.21. ALZECURE PHARMA has less than a 17 % chance of experiencing some financial distress in the next two years of operation and had a ok performance during the last 90 days. The performance scores are derived for the period starting the 23rd of April 2025 and ending today, the 22nd of July 2025. Click here to learn more.
AlzeCure Pharma AB , a pharmaceutical company, develops drug therapies for the treatment of Alzheimers and Parkinsons diseases. The company was founded in 2012 and is based in Huddinge, Sweden. ALZECURE PHARMA operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. The company has 59.19 M outstanding shares. More on ALZECURE PHARMA AB
Moving against ALZECURE Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
ALZECURE Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. ALZECURE PHARMA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ALZECURE PHARMA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) |
ALZECURE PHARMA AB (AC6) is traded on Frankfurt Exchange in Germany and employs 14 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.47 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ALZECURE PHARMA's market, we take the total number of its shares issued and multiply it by ALZECURE PHARMA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ALZECURE PHARMA AB classifies itself under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 59.19 M outstanding shares.
ALZECURE PHARMA AB has accumulated about 18.67 M in cash with 356.17 K of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.
Check ALZECURE PHARMA Probability Of Bankruptcy
Ownership AllocationALZECURE PHARMA holds a total of 59.19 Million outstanding shares. ALZECURE PHARMA AB retains noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check ALZECURE Ownership Details
ALZECURE PHARMA AB Risk Profiles
Although ALZECURE PHARMA's alpha and beta are two of the key measurements used to evaluate ALZECURE PHARMA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 11.16 | |||
| Semi Deviation | 13.14 | |||
| Standard Deviation | 15.21 | |||
| Variance | 231.35 |
ALZECURE Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in ALZECURE PHARMA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Other Information on Investing in ALZECURE Stock
ALZECURE PHARMA financial ratios help investors to determine whether ALZECURE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALZECURE with respect to the benefits of owning ALZECURE PHARMA security.